HRTX
Heron Therapeutics Inc
Price:  
3.44 
USD
Volume:  
1,108,083.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRTX Fair Value

-206.74 %
Upside

As of 2024-05-27, the Fair Value of Heron Therapeutics Inc (HRTX) is -3.67 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.44 USD, the upside of Heron Therapeutics Inc is -206.74%.

Note: valuation result may not be accurate due to the company's negative EPS.

3.44 USD
Stock Price
-3.67 USD
Fair Price
FAIR VALUE CALCULATION

HRTX Fair Value

Peter Lynch's formula is:

HRTX Fair Value
= Earnings Growth Rate x TTM EPS
HRTX Fair Value
= 6.83 x -0.54
HRTX Fair Value
= -3.67

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -204.70 -227.30 -220.70 -182.00 -110.56 -189.05
YoY growth -14.49% -11.04% 2.90% 17.54% 39.25% 6.83%

HRTX Fair Value - Key Data

Market Cap (mil) 518.24
P/E
Forward P/E
EPS -0.54
Avg earnings growth rate 6.83%
TTM earnings -80.95